Search results for "Hyla"

showing 10 items of 2227 documents

CCDC 1566411: Experimental Crystal Structure Determination

2017

Related Article: B. Dziuk, B. Ośmiałowski, A. Skotnicka, K. Ejsmont, B. Zarychta|2017|IUCrData|2|x171141|doi:10.1107/S2414314617011415

2-(4-(dimethylamino)phenyl)-33-difluoro-3H-naphtho[12-e][132]oxazaborinin-2-ium-3-uideSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 645204: Experimental Crystal Structure Determination

2008

Related Article: A.Ortiz, B.Insuasty, M.R.Torres, M.A.Herranz, N.Martin, R.Viruela, E.Orti|2008|Eur.J.Org.Chem.|2008|99|doi:10.1002/ejoc.200700718

2-Amino-46-bis(dimethylamino)-5-(tricyanovinyl)pyrimidineSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

NO donors. Part 16: investigations on structure-activity relationships of organic mononitrates reveal 2-nitrooxyethylammoniumnitrate as a high potent…

2007

The vasoactive properties of 14 organic mononitrates were investigated in vitro using PGF(2alpha)-precontracted porcine pulmonary arteries. A surprisingly wide range of vasorelaxant potencies was observed (pD(2): 3.36-7.50). Activities showed to be highly sensitive to the molecular structure and the substituents at the molecular carrier of the nitrate group. A correlation between lipophilicity and vasorelaxant potency could not be recognized. 2-Nitrooxyethylammoniumnitrate (1) was found to be slightly superior to the high potency trinitrate GTN.

2-nitrooxyethylammoniumnitrateNitratesChemistryStereochemistryVasodilator AgentsOrganic ChemistryClinical BiochemistryPharmaceutical ScienceVasodilationBiochemistryChemical synthesisIn vitroNo donorsQuaternary Ammonium CompoundsStructure-Activity RelationshipDrug DiscoveryLipophilicityMolecular MedicinePotencyStructure–activity relationshipNitric Oxide DonorsMolecular BiologyBioorganicmedicinal chemistry letters
researchProduct

CCDC 2194823: Experimental Crystal Structure Determination

2022

Related Article: Johanna M. Alaranta, Khai-Nghi Truong, María Francisca Matus, Sami A. Malola, Kari T. Rissanen, Sailee S. Shroff, Varpu S. Marjomäki, Hannu J. Häkkinen, Tanja M. Lahtinen|2022|Dyes Pigm.|208|110844|doi:10.1016/j.dyepig.2022.110844

2-{[2-(dimethylamino)-1-phenylpyridin-4(1H)-ylidene]methyl}-3-methyl-13-benzoxazol-3-ium chloride dihydrateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 2194826: Experimental Crystal Structure Determination

2022

Related Article: Johanna M. Alaranta, Khai-Nghi Truong, María Francisca Matus, Sami A. Malola, Kari T. Rissanen, Sailee S. Shroff, Varpu S. Marjomäki, Hannu J. Häkkinen, Tanja M. Lahtinen|2022|Dyes Pigm.|208|110844|doi:10.1016/j.dyepig.2022.110844

2-{[2-(dimethylamino)-1-phenylquinolin-4(1H)-ylidene]methyl}-3-methyl-13-benzothiazol-3-ium tetrafluoroborateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 852449: Experimental Crystal Structure Determination

2012

Related Article: Thomas H. Schneider, Max Rieger, Kay Ansorg, Alexandre N. Sobolev, Tanja Schirmeister, Bernd Engels, Simon Grabowsky|2015|New J.Chem.|39|5841|doi:10.1039/C5NJ00368G

3-(Methylamino)-3-(methylsulfanyl)-2-(phenylsulfonyl)acrylonitrileSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 149028: Experimental Crystal Structure Determination

2001

Related Article: A.Shivanyuk, M.Saadioui, F.Broda, I.Thondorf, M.O.Vysotsky, K.Rissanen, E.Kolehmainen, V.Bohmer|2004|Chem.-Eur.J.|10|2138|doi:10.1002/chem.200305633

46101216182224-Octahydroxy-281420-tetramethylcalix(4)arene bis(triethylammonium) dichloride clathrate acetonitrile solvateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 149027: Experimental Crystal Structure Determination

2001

Related Article: A.Shivanyuk, M.Saadioui, F.Broda, I.Thondorf, M.O.Vysotsky, K.Rissanen, E.Kolehmainen, V.Bohmer|2004|Chem.-Eur.J.|10|2138|doi:10.1002/chem.200305633

461618-Tetrahydroxy-10122224-tetrakis(p-tolylsulfonyloxy)-281420-tetraethylcalix(4)arene triethylammonium chloride clathrate ethanol solvateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 149024: Experimental Crystal Structure Determination

2001

Related Article: A.Shivanyuk, M.Saadioui, F.Broda, I.Thondorf, M.O.Vysotsky, K.Rissanen, E.Kolehmainen, V.Bohmer|2004|Chem.-Eur.J.|10|2138|doi:10.1002/chem.200305633

461618-Tetrahydroxy-10122224-tetrakis(p-tolylsulfonyloxy)-281420-tetrapentylcalix(4)arene bis(triethylammonium) dichloride clathrate acetonitrile solvateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 2194827: Experimental Crystal Structure Determination

2022

Related Article: Johanna M. Alaranta, Khai-Nghi Truong, María Francisca Matus, Sami A. Malola, Kari T. Rissanen, Sailee S. Shroff, Varpu S. Marjomäki, Hannu J. Häkkinen, Tanja M. Lahtinen|2022|Dyes Pigm.|208|110844|doi:10.1016/j.dyepig.2022.110844

4-[2-(dimethylamino)ethenyl]-2-(methylsulfanyl)-1-phenylquinolin-1-ium iodide monohydrateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct